Seeking Alpha

V.P. » Comments » Single Comment |

  • Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) [View article]
    Great article AW: You certainly are entitled to your opinion on TI!

    However, management has already burned $1.1 billion in develpoing TI. While the current $619 million should last them until 2009/10 (assuming their operating expenses go down as planned), I expect the FDA to adopt a cautious stance if and when the NDA for TI is filed. Tell me, how soon do you think the management can earn the $1.1 billion burnt in TI's development so far? Additionally, I do not see the management launching a new product in the coming 5 years based on their threadbare pipeline beyond TI.
    Jun 19 06:16 am |Rating: 0 0
All Comments by V.P. »
Comments by Ticker
V.P.'s
Comments Stats
3 comments
Rating: 0 (0 - 0 )